Literature DB >> 11942328

Histogenesis of nonurothelial carcinomas of the urinary bladder from pre-existent transitional cell carcinomas. A histopathological and immunohistochemical study.

E Kunze1, B Francksen.   

Abstract

The histogenesis of nonurothelial carcinomas of the urinary bladder is difficult to understand, since the bladder is normally lined exclusively by transitional cell epithelium. To gain more insights into the pathogenesis of nonurothelial carcinomas, the morphology and immunohistochemistry of transitional cell carcinomas (TCC), mixed transitional cell and nonurothelial carcinomas, and pure nonurothelial carcinomas were comparatively studied. Of papillary and of nonpapillary (solid) TCC (overall incidence 6.8%), 4.8% and 15.4%, respectively, disclosed foci of altered celllular and architectural phenotypes, consisting of squamous epithelium, pseudoglandular formations, and true glands with or without mucus production. The diverse phenotypic variants develop obviously by a metaplastic process as a result of the well-known inherent potential of the urothelium to undergo several pathways of cellular differentiation. There is strong evidence that squamous cell carcinomas arise secondarily from a squamous metaplasia and adenocarcinomas from metaplastic glandular epithelium within pre-existing TCC following complete carcinogenic transformation of the initially bland-looking metaplastic tumor cells. The metaplastic origin of nonurothelial bladder carcinomas is supported by immunohistochemical findings. The high molecular weight cytokeratin 34betaE12 identifies tumor cells with squamous characteristics, helping to explain the development of squamous cell carcinomas. Secretion of MUC5AC apomucin is assumed to play a central role in the histogenesis of nonurachal mucus-producing adenocarcinomas, including signet ring cell carcinomas. Metaplastic phenotypic variants of TCC should be recognized as distinct tumor entities with the potential to transform into nonurothelial carcinomas and thus possibly implying a poorer clinical outcome than typical, uniform TCC.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11942328     DOI: 10.1007/s00240-001-0232-3

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  5 in total

1.  Metastatic signet-ring cell cancer of the bladder responding to chemotherapy with capecitabine: case report and review of literature.

Authors:  Jorg Michels; Sean Barbour; Douglas Cavers; Kim N Chi
Journal:  Can Urol Assoc J       Date:  2010-04       Impact factor: 1.862

2.  The impact of signet-ring cell carcinoma histology on bladder cancer outcome.

Authors:  Jue Wang; Fen Wei Wang; Anne Kessinger
Journal:  World J Urol       Date:  2011-06-25       Impact factor: 4.226

3.  Transitional cell carcinoma with glandular differentiation metastatic to the inguinal lymph node from the urinary bladder.

Authors:  Emin Ozbek; Alper Otunctemur; Murat Dursun; Adnan Somay
Journal:  Indian J Urol       Date:  2014-01

Review 4.  Clinical implications of caveolins in malignancy and their potential as therapeutic targets.

Authors:  Ila Tamaskar; Ming Zhou
Journal:  Curr Oncol Rep       Date:  2008-03       Impact factor: 5.075

5.  Patterns of invasion and histological growth as prognostic indicators in urothelial carcinoma of the upper urinary tract.

Authors:  C Langner; G Hutterer; T Chromecki; P Rehak; R Zigeuner
Journal:  Virchows Arch       Date:  2006-03-09       Impact factor: 4.064

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.